DOI: https://doi.org/10.24959/uekj.20.28

Methodological approaches to identifying and assessing risks of socially responsible activities of pharmaceutical companies

Yu. S. Bratishko, O. V. Posylkina

Abstract


The aim of the study is to identify the current types of risks inherent in the socially responsible activities of pharmaceutical companies, and to develop methodological approaches to their classification in accordance with international standards and taking into account the specifics of the functioning of pharmaceutical industry entities.

Materials and methods: analysis, synthesis, empirical methods, control survey method, modeling method.

Results. Based on the results of the analysis, a list of risks that may arise as a result of socially responsible activities by pharmaceutical industry entities was determined. As a result of the content analysis, classification characteristics of risks of social responsibility of the pharmaceutical business are determined. The risks of social responsibility were grouped according to classification characteristics. A survey of experts was conducted on the importance of certain types of risks of socially responsible activities of pharmaceutical companies. It is justified that modern pharmaceutical companies require modern methodological tools and organizational support for effective risk management of socially responsible activities by identifying these risks, assessing them and developing mechanisms for their minimization.

Conclusions. It has been proved that, together with the existence of significant strategic advantages in the implementation of socially responsible activities by pharmaceutical companies, this activity has a significant list of risks. These risks it is necessary to identify, reveal, estimate and operate them for increase in efficiency of social responsibility of pharmaceutical business. It was revealed that a certain range of risks of social responsibility are not manageable, they cannot be avoided, and their existence is due to the natural laws of the development of the pharmaceutical business and the desire of pharmaceutical companies to improve their own reputation and competitiveness. That is, today, for every pharmaceutical company that goes along the path of social responsibility, it is necessary to use modern methodological tools to identify, assess and manage the risks of social responsibility of the pharmaceutical business to ensure the conditions of sustainable socio-economic development.

Keywords


social responsibility; risk; identification of risks; risk management; pharmaceutical company

References


Bowen, H. R. (1953). Social responsibilities of the businessman. New York: Harper & Brothers.

Carroll, A. B. (1979). A Tree–Dimensional Conceptual Model of Corporate Performance. Academy of Management Review, 4 (4), 497–505.

Carroll, A. B. (1991). The pyramid of corporate social responsibility: Toward the moral management of organizational stakeholders. Business Horizons, 34 (4), 39–48.

Carroll, A. B. (2004). Managing ethically with global stakeholders: A present and future challenge. Academy of Management Executive, 18 (2), 114–120.

Davis, K. (1967). Understanding the social responsibility puzzle. Business Horizons, 10 (4), 45–50.

Davis, K. (1973). The Case for and Against Business Assumption of Social Responsibilities. Academy of Management Journal, 16 (2), 312–322.

Davis, K. (1960). Can Business Afford to Ignore Social Responsibilities? California Management Review, 2 (3), 70–76.

Zhuk, M. S., Shkurat. M. S., Lukianikhin V. O. (2014). Proceeding from Ekonomichni problemy staloho rozvytku: materialy mizhnar. nauk.-prakt. konf., (6–8 trav. 2014 r.). (pp. 271–272). Sumy.

Melashich, Zh., Starinecz, I. Strakhovij klub KNEU. Available at: http://pck.kneu.edu.ua/?p=174.

Zarichkova, M. V. (2016). Research of existing risks with employees of pharmacy institutions and classi fication of risks by different types of safety. Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, 4, 32–37.

Cherkashyna, А. V., Kotvitska A. A. (2014). Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, 3, 36–42.

Tkachenko, N. O., Chervonenko, N. M., Knysh, Ye. H. (2013). Zaporozhskii med. zhurn, 2, 76–82.

Tolochko, V. M., Zarichkova, M. V. (2014). Proceeding from Sotsialna farmatsiia : stan, problemy ta perspektyvy: mizhnar. nauk.-prakt. Internet-konf. (17–20 berez. 2014 r.). (pp. 128–132). Kharkiv.

Governance Risk Compliance. Available at: https://www2.deloitte.com/content/dam/Deloitte/global/Documents/Governance-Risk-Compliance/ dttl-grc- exploring-strategic-risk.pdf.


GOST Style Citations


1.   Bowen H. R. Social responsibilities of the businessman.New York: Harper & Brothers, 1953.

 

2.   Carroll A. B. A Three-Dimensional Conceptual Model of Corporate Performance. Academy of Management Rev. 1979. Vol. 4, Iss. 4. P. 497–505.

 

3.   Carroll A. B. The Pyramid of Corporate Social Responsibility: Toward the Moral. Management of Organizational Stakeholders. Business Horizons. 1991. Vol. 34, Iss. 4. P. 39–48.

 

4.   Carroll A. B. Managing ethically with global stakeholders : A present and future challenge. Academy of Management Executive. 2004. Vol. 18, Iss. 2. P. 114–120.

 

5.   Davis K. Understanding the social responsibility puzzle. Business Horizons. 1967. Vol. 10, Iss. 4. P. 45–50.

 

6.   DavisK. The Case for and Against Business Assumption of Social Responsibilities. Academy of Management J. 1973. Vol. 16, Iss. 2. P. 312–322.

 

7.   DavisK. Can Business Afford to Ignore Social Responsibilities? California Management Rev. 1960. Vol. 2, Iss. 3. P. 70–76.

 

8.   Жук М. С., Шкурат М. С., Лук’янихін В. О. Ризики, пов’язані з корпоративною соціальною відповідальністю компанії. Економічні проблеми сталого розвитку : матеріали Міжнар. наук.-практ. конф., м. Суми, 6–8 трав. 2014 р. Суми, 2014. С. 271–272.

 

9.   Мелашич Ж., Старінець І. Корпоративна соціальна відповідальність як елемент стратегії підприємства: можливості та ризики. Страховий клуб КНЕУ URL: http://pck.kneu.edu.ua/?p=174 (дата звернення: 20.07.2020).

 

10. Zarichkova M. V. Research of existing risks with employees of pharmacy institutions and classification of risks by different types of safety. Управління, економіка та забезпечення якості в фармації. 2016. № 4. С. 32–37. URL: http://nbuv.gov.ua/UJRN/Uezyaf_2016_4_7 (дата звернення: 20.07.2020).

 

11. Черкашина А. В., Котвіцька А. А. Дослідження сучасного стану соціальної відповідальності найбільших аптечних мереж міста Харкова. Управління, економіка та забезпечення якості в фармації. 2014. № 3. С. 36–42.

 

12. Ткаченко Н. О., Червоненко Н. М., Книш Є. Г. Сучасний стан і характеристика соціальної відповідальності підприємницької діяльності. Запорожский мед. журн. 2013. № 2. С. 76–82.

 

13. Толочко В. М., Зарічкова М. В. Посилення соціальної відповідальності в діяльності аптечних закладів України. Соціальна фармація : стан, проблеми та перспективи : міжнар. наук.-практ. Інтернет-конф., 17–20 берез. 2014 р. Харків, 2014. C. 128–132.

 

14. Governance Risk Compliance. URL: https://www2. deloitte. com/content/dam/Deloitte/global/Documents/Governance-Risk-Compliance/ dttl-grc- exploring -strategic-risk.pdf (Date of access: 01.07.2020).





Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Abbreviated key title: Manag. econ. qual. assur. pharm.

ISSN 2519-8807 (Online), ISSN 2311-1127 (Print)